Loading...
P06.13 A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab
A subset of patients with recurrent high-grade gliomas benefits from the anti-angiogenic therapy bevacizumab (BVZ). An increased number of research efforts are performed to develop predictive biomarkers that allow for screening of patients. The immune system plays a crucial role in angiogenesis indu...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782602/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.104 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|